Publicacións nas que colabora con Vicente Bertomeu Martinez (74)

2024

  1. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

    Scientific Reports, Vol. 14, Núm. 1

2020

  1. A simple score to select patients for manual thrombectomy in emergent percutaneous coronary interventions: The DDTA score

    Journal of Cardiovascular Medicine, Vol. 21, Núm. 8, pp. 595-602

2019

  1. Causes of Higher In-hospital Mortality Due to ACS in the Canary Islands and Possible Solutions

    Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 443-444

  2. Comentarios a la guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 104-108

  3. Hemorrhage in patients under oral anticoagulation for atrial fibrillation. The other side of the coin

    REC: CardioClinics, Vol. 54, Núm. 2, pp. 99-105

  4. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome

    International Journal of Cardiology, Vol. 276, pp. 20-25

  5. Initial Real-world Experience With PCSK-9 Inhibitors in Current Indications for Reimbursement in Spain

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 968-970

2018

  1. Addition of Antiangina Drugs and Recurrent Cardiovascular Events Associated With Incomplete Revascularization in Acute Coronary Syndrome

    Revista Espanola de Cardiologia, Vol. 71, Núm. 3, pp. 217-219

  2. Association analysis between hyperuricemia and long term mortality after acute coronary syndrome in three subgroups of patients

    Data in Brief

  3. Cancer and Acute Coronary Syndrome. A Close, but Complicated Relationship. Response

    Revista Espanola de Cardiologia

  4. Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study (PLoS ONE (2017) 12:10 (e0186196) DOI: 10.1371/journal.pone.0186196)

    PLoS ONE

  5. Hyperuricemia as a prognostic factor after acute coronary syndrome

    Atherosclerosis, Vol. 269, pp. 229-235

  6. Prevalence and Postdischarge Incidence of Malignancies in Patients With Acute Coronary Syndrome

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 267-273

  7. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication

    International Journal of Cardiology, Vol. 270, pp. 36-41

  8. Reply to: “Determination of the optimal cut-off value of serum uric acid concentration in patients with acute coronary syndrome”

    Atherosclerosis

2017

  1. Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes

    International Journal of Cardiology, Vol. 245, pp. 1-5

  2. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design

    Revista Espanola de Cardiologia, Vol. 70, Núm. 12, pp. 1067-1073

  3. Initial experience with bioresorbable vascular scaffolds for percutaneous revascularisation in patients with acute coronary syndrome

    Vessel Plus, Vol. 1, pp. 68-76

  4. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

    PLoS ONE, Vol. 12, Núm. 10

  5. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study

    Cardiovascular Therapeutics, Vol. 35, Núm. 2